Latest News

Almogim Holdings (TASE:ALMA) just posted its Q3 2025 results, reporting revenue of 80.4 million ILS and basic EPS of 0.04 ILS. Looking back, the company has seen revenue climb from 53.6 million ILS a year ago in Q2 2024, while EPS over that same period moved from 0.02 ILS to 0.04 ILS. Margins came under the spotlight this quarter as investors weighed the numbers against historical trends. See our full analysis for Almogim Holdings. Now let’s see how these fresh numbers stack up against the...

Key Insights Mitsui's significant individual investors ownership suggests that the key decisions are influenced by...

Blue Square Real Estate (TASE:BLSR) just published its Q3 2025 results, posting total revenue of ₪154.56 million and basic EPS of ₪24.99. For historical context, over the past six quarters, revenue has ranged from ₪150.89 million to ₪366.10 million, while EPS has tracked between ₪6.37 and ₪24.99. Margins remain a key focal point for investors as they weigh the implications of these current results. See our full analysis for Blue Square Real Estate. Next up, we will put these numbers side by...

G City (TASE:GCT) just posted its Q3 2025 results, reporting revenue of 704 million ILS and a basic EPS of -0.06 ILS. The company has seen revenue ranging from 568 million ILS to 704 million ILS per quarter over the past year, with quarterly EPS consistently in negative territory except for Q2. Margins remain pressured as profitability remains lackluster, giving investors plenty to consider. See our full analysis for G City. Next, we compare these figures with the widely followed narratives...

Wondering if United Therapeutics might be a hidden gem or already fully priced? You are not alone, and the real answer lies deeper than just the current share price. The stock has delivered a robust 34.9% gain year-to-date and climbed an impressive 31.2% over the past 12 months. This signals strong momentum and growing investor confidence. Recent headlines highlight the company’s expanding efforts in pulmonary arterial hypertension treatments and the successful advancement of its organ...

Earlier this week, Newborn Town Inc. announced that Three D Partners Limited acquired an additional 2,052,000 shares under the company's RSU Award Scheme. This action underscores Newborn Town's focus on boosting shareholder value while signalling institutional support for its innovation-driven business model. We'll explore how the significant share purchase by Three D Partners Limited could impact Newborn Town’s investment narrative moving forward. AI is about to change healthcare. These 30...

Issta (TASE:ISTA) just posted its Q2 2025 numbers, reporting revenue of ₪111.98 million and EPS of ₪0.35. For context, revenue was ₪93.82 million with EPS of ₪1.37 in Q1 2025, while Q4 2024 saw revenue at ₪109.42 million and EPS of ₪1.63. Margins remained under pressure, painting a mixed picture for investors focused on signs of sustainable profitability. See our full analysis for Issta. Next, we examine the latest results in light of current narratives and market expectations, so you can see...

Ever wondered if Jamf Holding is a hidden gem or a value trap? You are not alone. Many investors are looking for an edge in judging whether this tech stock is priced right. Despite a recent flat patch, with the share price creeping up just 0.5% in the past week and slipping 8.2% year-to-date, big swings in long-term performance could point to shifting sentiment and maybe even new opportunities on the horizon. Jamf has been in the headlines lately with partnerships and new product launches...

Banco Latinoamericano de Comercio Exterior S. A (NYSE:BLX) has delivered a steady month of growth, with its stock price climbing 6% over the past month. Investors are watching to see if this momentum can continue, especially given the bank's focus on trade financing across Latin America and the Caribbean. See our latest analysis for Banco Latinoamericano de Comercio Exterior S. A. Banco Latinoamericano de Comercio Exterior S. A’s 26% share price return so far this year signals a resurgence in...

In recent news, Compañía de Minas BuenaventuraA reported a 44% compound annual growth in earnings per share over the last three years, with EBIT margins expanding from 17% to 27% and revenue continuing to rise. Management's alignment with shareholders is highlighted by insider ownership of 17%, underlining confidence in the company's sustained profit growth and financial health. We will explore how these improvements in profitability and insider alignment could influence Buenaventura's...

O.Y. Nofar Energy (TASE:NOFR) has just posted its Q2 2025 results, reporting revenue of 105.7 million ILS and a basic EPS of -1.34 ILS for the quarter, alongside a net income loss of 47.5 million ILS. Historically, the company’s revenue moved from 101.5 million ILS in Q2 2024 to 105.7 million ILS this quarter. EPS fell from -0.15 ILS to -1.34 ILS over the same periods. Margins continue to be a focal point, with the latest figures highlighting persistent pressure on profitability. See our full...

Wondering if Fairfax Financial Holdings is fairly priced or a hidden bargain? You are not alone, as many investors are watching closely to see if now is the right time to jump in or hold steady. The stock has delivered a steady 21.7% gain year-to-date, with a 6.8% bump in the last month and an eye-catching 470.0% return over five years, catching the attention of both long-term holders and newcomers. Recent headlines have highlighted Fairfax’s ongoing global acquisitions strategy. The company...

Wondering if Restaurant Brands International is trading at a bargain or looks overheated? You are not alone; we are diving into what its numbers tell us about value right now. The stock is up 2.7% in the last week and has climbed 9.6% over the past month, which suggests shifting sentiment and renewed interest in its growth story. Headlines have focused on the company’s bold expansion efforts and ongoing brand revamps. Investors hope these changes could propel future sales. The buzz was...

ATRenew (NYSE:RERE) just posted third-quarter results showing net income growth and a return to profitability over the past nine months. The company also provided strong revenue guidance for the rest of 2025. This combination is attracting fresh investor attention. See our latest analysis for ATRenew. After a tough stretch earlier in the year, ATRenew's momentum has turned sharply positive. Fresh earnings and robust guidance have helped the stock deliver a 59% share price return year-to-date,...

Wondering if Select Medical Holdings is fairly priced, overlooked, or potentially a hidden value? You are not alone, as many investors are eyeing the stock for hints of opportunity. Over the past week, Select Medical has jumped 13.4%, building on an 8.4% gain over the last month, even as it remains down 17.6% year to date. Recent market excitement has been driven by industry-wide discussions about evolving healthcare regulations and strategic partnerships across the sector...

Wondering if Millrose Properties could be a hidden gem or just another overvalued name on the NYSE? You are not alone. Savvy investors know that true value is more than just a stock price. The stock has climbed an impressive 38.8% year-to-date, though it has recently come off its highs with a 5.1% drop over the last month. This kind of movement catches the eye, whether you are chasing momentum or wary of shifting risk. Recent headlines have put Millrose Properties in the...

Earlier this month, Accent Group Limited released updated earnings guidance for the 2026 financial year, forecasting first half EBIT in the A$55 million to A$60 million range and full-year EBIT between A$85 million and A$95 million, accounting for nonrecurring losses from closing its MySale operations. A unique aspect of this update is the explicit inclusion of nonrecurring losses tied to the MySale closure, providing a more transparent view of the company’s operational expectations and cost...

With its stock down 11% over the past three months, it is easy to disregard Hyundai Glovis (KRX:086280). But if you pay...

Ever wondered if Academy Sports and Outdoors stock is trading at a bargain or carrying a hidden premium? You are not alone; investors everywhere are asking whether now is the right time to buy or watch from the sidelines. The stock has caught some attention lately, climbing 9.2% this past week, even as it is still down nearly 15% year-to-date and just about flat over the last year. One reason for the recent moves is sector-wide optimism following positive consumer spending data, which has...

Thinking about whether Raymond James Financial is worth your investment attention? Let’s dig into what the numbers and some recent events might mean for its true value. The stock has shown some short-term momentum with a 2.3% gain over the past week, though it remains roughly flat year-to-date and is still down 6.3% over the last year after strong gains in the past few years. Recent headlines have focused on Raymond James Financial’s expansion of its wealth management services and strategic...

Vitania (TASE:VTNA) has just posted its Q2 2025 results, with revenue coming in at ₪75.9 million and a basic EPS of -₪0.98. Net income (excluding extra items) stood at -₪46.3 million for the period. The company has seen revenue fluctuating between ₪58.0 million and ₪89.9 million over the last six quarters, with EPS ranging from ₪0.19 to ₪1.07 before most recently turning negative. Margins remain in focus as investors consider these results in the context of ongoing volatility in profitability...

Aspen Group (TASE:ASGR) just released its Q3 2025 results, reporting total revenue of 53.201 million ILS and basic EPS of 0.182456 ILS. Over prior quarters, revenue hovered in a tight range from 51.9 million ILS to 54.902 million ILS. Basic EPS moved between -0.395787 and 0.182456 ILS. Margins remain under the microscope as investors look for signs of stabilization in the company’s bottom line amid a stretch of uneven profitability. See our full analysis for Aspen Group. Next, we will size up...

Orca Energy Group (TSXV:ORC.B) posted Q3 2025 financial results with total revenue of $21.7 million and EPS of $0.99. Looking at recent trends, the company saw revenue slip from $24.8 million in Q3 2024, though EPS moved up from $0.11. For investors, profit margins remain in focus as the overall results reflect a period of shifting earnings power. See our full analysis for Orca Energy Group. Next, we will examine how the latest numbers compare to prevailing investor narratives and where...

Precigen (PGEN) recently received FDA approval for PAPZIMEOS in adults with recurrent respiratory papillomatosis and secured a new credit facility, which extends its cash runway into 2027 and supports its cash flow breakeven goals. See our latest analysis for Precigen. Precigen’s share price story this year has been equally dramatic, with a year-to-date gain of 254.6% following FDA approval news and the extended credit facility. Short-term price swings remain volatile. The company’s 1-year...